Unresectable Cholangiocarcinoma

7 clinical trials · Condition

Record	Firm	Date
Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma (NCT04088188)	Academic and Community Cancer Research United	2021-01-25
Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Perihilar Cholangiocarcinoma. A Prospective Multicenter Study. (NCT04378023)	Hospital Vall d'Hebron	2020-04-24
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver (NCT04175912)	National Cancer Institute (NCI)	2020-03-16
A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma (NCT03656536)	Incyte Corporation	2019-06-03
Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer (NCT03201458)	National Cancer Institute (NCI)	2018-02-08
A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma (NCT03250273)	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	2017-11-06
Photodynamic Therapy (PDT) Cholangiocarcinoma Registry (NCT01524146)	Weill Medical College of Cornell University	2011-11-01

Every clearance here is in the API, with alerts when new ones post.